Directorate ChangeSource: RNS
Appointment of Chairman and Senior Independent Director
Elementis plc (ELM.L) (the "Company"), global specialty chemicals company, today announces the appointment of John O'Higgins as Non-Executive Chairman of the Company, effective from 1 September 2021. This follows the announcement in March 2021 that Andrew Duff, Chairman, would be stepping down from the Board this year, and a thorough, externally facilitated, recruitment process.
John will also chair the Nomination Committee. John was appointed as a Non-Executive Director on 4 February 2020 and became Senior Independent Director on 29 April 2020. Prior to joining Elementis, John served as chief executive of Spectris plc from January 2006 to September 2018, leading the business through a period of significant strategic transformation and development. Prior to Spectris plc, John spent 14 years at Honeywell International in a number of senior management roles.
Steve Good, Non-Executive Director since 20 October 2014 and Chair of the Remuneration Committee since 25 April 2017, will succeed John as Senior Independent Director, with effect from 1 September 2021.
The Company thanks Andrew for his strong leadership, hard work and commitment over the past seven years. As Chairman, Andrew has overseen the transformation of the Company into a higher quality business and leaves the Company well-positioned for continued success.
Andrew Duff, Chairman, said: "It has been a privilege to chair the Board of Elementis and I wish John, the Board and the Company every success in the future."
On his appointment as Chairman, John O'Higgins said: "On behalf of the Board and everyone at Elementis, I would like to thank Andrew for the enormous contribution he has made during his tenure as Chairman and to wish him the very best for the future. It is a great honour to take on the role of Chair at Elementis. I look forward to working with Paul, the executive team and the Board to continue to execute the Group's strategy and deliver our medium term performance objectives."
The Company confirms that there are no other matters requiring disclosure pursuant to LR 9.6.13R (1) to (6) in respect of the appointments.
0207 067 2999